EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Cosmax Inc (192820) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Cosmax Inc KRW 218,255, price KRW 272,000, upside -19.8%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · KR · ISIN KR7192820009

CI Some data Sep 24, 2026

Cosmax Inc

192820 · KO

Weak valuationQuality is weak on top of the rich price.

!Fair value 218,255 KRW · Overvalued (−20%)
!Quality 49/100
!Expensive Growth (revenue 5y +11.6 %/yr)
!Thin margins · 6.3% net margin (TTM)
!Low debt · negative free cash flow
·1.21% dividend yield
!Mixed vs. peers (5/9)
!Moderate moat 55/100
!Insider activity 45/100
!Evidence only medium, so the estimate is less certain
!Weak on valuation: 7 out of 100
!Weak on dividend: 24 out of 100
Watch Cosmax Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

303,000 KRW 40,756 KRW Fair Value 218,255 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 40,756 KRW – 303,000 KRW · fair‑value band 152,779 KRW – 284,729 KRW · the 272,000 KRW price screens above the 218,255 KRW fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Cosmax in your weekly email

Every Wednesday you see whether Cosmax is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments.

Show more

Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.

Stock analysis

Cosmax Inc (192820) currently trades at 272,000 KRW, while our model-based Fair Value estimate is 218,255 KRW, implying the stock looks roughly 24.6% overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 224,128 KRW per share, and 3 of the 15 models we run sit above the 272,000 KRW price.

Bear case: the Asset-Based group reads lowest at 32,961 KRW, and 12 of the 15 models stay below the price. Evidence for this calculation is medium.

Scenario range: 152,779 KRW (bear) to 284,729 KRW (bull), the price of 272,000 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 49/100 (below-average quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Cosmax Inc reported revenue of 2.4T KRW in FY2025 versus 1.6T KRW in FY2021, a compound +10.8%/yr. Reported net income was 123B KRW in FY2025, compounding +13.4%/yr from FY2021.

Key figures

Market cap 3.1T KRW (≈ $2.2B) · P/S ratio 0.82 · Dividend yield 1.2% · Net margin 5.1% · Return on equity 28.9% · Return on assets (EBIT) 7.6% · Operating margin 7.8% · Revenue (TTM) 2.5T KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).

What moves the price

The share trades about 10% below its 52-week high and 88% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −25% fair-value upside, at −20%, 192820 screens cheaper than that median.

Fair Value models

Bear 152,779 KRW Fair Value 218,255 KRW Bull 284,729 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Owner Earnings 38,929 KRW 67,363 KRW 112,305 KRW 74
EPV 106,865 KRW 121,466 KRW 133,634 KRW 74
ROIC Compounder 119,805 KRW 152,939 KRW 192,411 KRW 72
All 15 models by family
DCF Models
Owner Earnings 38,929 KRW 67,363 KRW 112,305 KRW 74
Earnings-Based
Graham-Dodd 73,758 KRW 370,141 KRW 510,906 KRW 64
Lynch FV 100,224 KRW 143,178 KRW 186,131 KRW 61
PEG = 1.0 100,224 KRW 143,178 KRW 186,131 KRW 57
EPV 106,865 KRW 121,466 KRW 133,634 KRW 74
Multiples
P/E Multiple 170,837 KRW 227,783 KRW 284,729 KRW 63
P/S Multiple 138,297 KRW 184,396 KRW 230,495 KRW 58
P/B Multiple 138,297 KRW 184,396 KRW 230,495 KRW 55
EV/EBIT 219,814 KRW 293,156 KRW 366,498 KRW 66
EV/EBITDA 231,765 KRW 309,091 KRW 386,417 KRW 67
EV/Revenue 156,826 KRW 224,128 KRW 291,430 KRW 53
Asset-Based
NCAV (Graham) 24,598 KRW 32,961 KRW 49,196 KRW 54
Economic Profit
Residual Income 61,370 KRW 81,866 KRW 296,833 KRW 64
ROIC Compounder 119,805 KRW 152,939 KRW 192,411 KRW 72
Growth Earnings
Growth-Adj P/E 152,779 KRW 218,255 KRW 283,732 KRW 67

Open the full fair value analysis →

Notify me when 192820 reaches fair value

Put 192820 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 49/100

Of which business quality 45 · Market factors (momentum, volatility) 73

Profitability 55
Margins and returns on capital today
Quality Growth 43
Are margins and returns improving?
Cashflow 10
Earnings quality: real cash, not paper profit
Fin. Strength 38
Balance sheet, leverage, solvency risk
Investment 64
Disciplined investing over empire-building
Low Volatility 45
Calm price path (market factor)
Momentum 91
Price trend over the last 3–12 months (market factor)
52W Momentum 74
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+10.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.6%
Start year 2020 (pandemic). Over 10 years: +16.2% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.6%
What shareholders gained per year (last 5 years), in KRW (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+40.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+39.0%
Dividend (yield on the price)1.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 8%
2025 sits 115% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

192820 screens 25% overvalued. Compare with The Procter & Gamble Company →

Compare Cosmax Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 250 stocks

Beats the industry median on 5/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 49 · Below median
Fair Value upside −20% · Below median
Profitability
Return on equity (TTM) 29% · Top 25%
Return on assets 5% · Above median
Net margin (TTM) 6% · Above median
Operating margin (TTM) 8% · Above median
Growth and dividend
Revenue growth 16% · Top 25%
Dividend yield (TTM) 1.2% · Bottom 25%
Balance sheet
Debt / equity 0.35× · Highest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)7 · sector 33
FUTURE (revenue growth)80 · sector 9
PAST (return on equity)100 · sector 28
HEALTH (low debt)83 · sector 98
DIVIDEND (yield)24 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $148.22 $110.45 −25%
Colgate-Palmolive Company CL $87.05 $55.95 −36%
Hindustan Unilever Limited HINDUNILVR ₹1,950 ₹775.25 −60%
Kenvue Inc KVUE $17.86 $12.73 −29%
Kimberly-Clark Corporation KMB $98.91 $83.93 −15%
Henkel AG HEN €69.30 €80.96 +17%
The Estée Lauder Companies Inc EL $100.29 $27.22 −73%
Church & Dwight Co CHD $96.12 $65.12 −32%
Beiersdorf Aktiengesellschaft, BEI €76.46 €68.95 −10%
Puig Brands, S.A PUIG €17.56 €19.32 +10%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cosmax Inc · Fair Value
218,255 KRW −25%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Cosmax Inc Fair Value". https://www.fairvalue-calculator.com/stock/192820

Frequently asked questions

Is Cosmax Inc (192820) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 218,255 KRW versus a price of 272,000 KRW, about −20% upside (overvalued).
What is the fair value of 192820?
Our model-based fair value for Cosmax Inc is 218,255 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 272,000 KRW.
What is the quality score of 192820?
Cosmax Inc has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cosmax Inc (192820)?
Our model-based price target is the fair value of 218,255 KRW (as of Sep 24, 2026) from 15 valuation models. Cautious scenario 152,779 KRW, optimistic scenario 284,729 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Cosmax Inc stock forecast for 2026?
Our models put fair value at 218,255 KRW, about −20% upside versus a price of 272,000 KRW (overvalued). Cautious scenario 152,779 KRW, optimistic scenario 284,729 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Cosmax Inc (192820)?
Cosmax Inc reported trailing-twelve-month revenue of about 2.5T KRW (latest available figure, as of Sep 24, 2026).
Does Cosmax Inc pay a dividend?
Cosmax Inc currently shows a dividend yield of about 1.21% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Cosmax Inc (192820)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cosmax Inc it is 218,255 KRW per share (as of Sep 24, 2026), against a price of 272,000 KRW. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is Cosmax Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 192820 trades above its calculated fair value: price 272,000 KRW, fair value 218,255 KRW, a gap of about −20% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 192820?
No. The price is what the market pays today (272,000 KRW); the fair value is what the company's own numbers justify (218,255 KRW). For Cosmax Inc the two are 53,745 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Cosmax Inc worth?
The market values Cosmax Inc at about 3.1T KRW (market capitalisation, as of Sep 24, 2026). Per share that is 272,000 KRW; our models calculate a fair value of 218,255 KRW per share.
What do the bullish and bearish scenarios say about 192820?
Our models span a range for Cosmax Inc: cautious scenario 152,779 KRW, base 218,255 KRW, optimistic 284,729 KRW per share (as of Sep 24, 2026, price 272,000 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cosmax Inc (192820)?
Balance-sheet figures for Cosmax Inc (as of Sep 24, 2026): return on equity 28.9%, debt of 0.35 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 192820 from its 52-week high?
Cosmax Inc trades at 272,000 KRW, about 10% below its 52-week high of 303,000 KRW and 88% above the low of 144,900 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 218,255 KRW is for.
Which stocks are comparable to Cosmax Inc?
From the same area (Consumer Defensive) we also value The Procter & Gamble Company, Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cosmax Inc stock attractive at the current price?
The data as of Sep 24, 2026: price 272,000 KRW, calculated fair value 218,255 KRW (−20%), Quality Score 49/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 192820 calculated?
We run Cosmax Inc through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 218,255 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Cosmax Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cosmax Inc (192820)?
The closing price on Sep 23, 2026 was 272,000 KRW. Our model-based fair value is 218,255 KRW, about −20% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cosmax Inc right now?
Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (152,779 KRW to 284,729 KRW) leaves room in how you read the outcome.

Key figures of Cosmax Inc

How large is the market capitalisation of Cosmax Inc (192820)?
The market capitalisation of Cosmax Inc is 3.1T KRW (≈ $2.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cosmax Inc (192820)?
The price-to-sales ratio of Cosmax Inc is 0.82 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Cosmax Inc (192820)?
The dividend yield of Cosmax Inc is 1.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cosmax Inc (192820)?
The net margin of Cosmax Inc is 5.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cosmax Inc (192820)?
The return on equity (ROE) of Cosmax Inc is 28.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cosmax Inc (192820)?
On an EBIT basis the return on assets of Cosmax Inc is 7.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cosmax Inc (192820)?
The operating margin of Cosmax Inc is 7.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cosmax Inc (192820)?
Revenue at Cosmax Inc is growing +15.9% versus a year earlier (3y avg +14.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cosmax Inc (192820)?
Earnings per share at Cosmax Inc are growing +411% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Cosmax Inc (192820) generate?
The free cash flow of Cosmax Inc is −106B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Cosmax Inc (192820) carry?
The net debt of Cosmax Inc is 586B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Cosmax Inc in the live analysis

One click puts Cosmax Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.